Hospitalization costs among immobile patients with hemorrhagic or ischemic stroke in China: a multicenter cross-sectional study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Hemorrhagic Stroke/*therapy ; Hospitalization/*economics ; Immobilization/*statistics & numerical data ; Ischemic Stroke/*therapy; Adolescent ; Adult ; Aged ; China ; Costs and Cost Analysis/statistics & numerical data ; Cross-Sectional Studies ; Female ; Humans ; Length of Stay/statistics & numerical data ; Male ; Middle Aged ; Young Adult
    • Abstract:
      Background: In this study, we aimed to analyze the hospitalization costs for immobile patients with hemorrhagic stroke (IHS) or ischemic stroke (IIS) in China and to determine the factors associated with hospitalization costs.
      Methods: We evaluated patients with IHS and IIS hospitalized between November 2015 and July 2016 in six provinces or municipality cities of China. Linear regression analysis was used to examine the association with hospitalization costs and predictors.
      Results: In total, 1573 patients with IHS and 3143 with IIS were enrolled and analyzed. For IHS and IIS, the average length of stay (LoS) was 17.40 ± 12.3 and 14.47 ± 11.55 days. The duration of immobility was 12.11 ± 9.98 and 7.36 ± 9.77 days, respectively. Median hospitalization costs were RMB 47000.68 (interquartile range 19,827.37, 91,877.09) for IHS and RMB 16578.44 (IQR 7020.13, 36,357.65) for IIS. In both IHS and IIS groups, medicine fees accounted for more than one-third of hospitalization costs. Materials fees and medical service fees accounted for the second and third largest proportions of hospital charges in both groups. Linear regression analysis showed that LoS, hospital level, and previous surgery were key determinants of hospitalization costs in all immobile patients with stroke. Subgroup analysis indicated that hospital level was highly correlated with hospitalization costs for IHS whereas pneumonia and deep vein thrombosis were key factors associated with hospitalization costs for IIS.
      Conclusions: We found that hospitalization costs were notably higher in IHS than IIS, and medicine fees accounted for the largest proportion of hospitalization costs in both patient groups, perhaps because most patients ended up with complications such as pneumonia thereby requiring more medications. LoS and hospital level may greatly affect hospitalization costs. Increasing the reimbursement ratio of medical insurance for patients with IHS is recommended. Decreasing medicine fees and LoS, preventing complications, and improving treatment capability may help to reduce the economic burden of stroke in China.
    • References:
      Neuroepidemiology. 2018;50(1-2):63-73. (PMID: 29421788)
      Eur J Intern Med. 2016 Apr;29:9-21. (PMID: 26723523)
      Eur Neurol. 2002;48(3):133-40. (PMID: 12373029)
      Lancet Neurol. 2011 Apr;10(4):357-71. (PMID: 21247806)
      Stroke. 2011 Dec;42(12):3651-4. (PMID: 22052510)
      J Rehabil Med. 2015 Feb;47(2):120-5. (PMID: 25268933)
      Nat Neurosci. 2010 Dec;13(12):1444-6. (PMID: 21102566)
      Neurology. 2016 Nov 15;87(20):2091-2098. (PMID: 27760870)
      Lancet Neurol. 2020 Mar;19(3):255-265. (PMID: 31813850)
      Lancet Neurol. 2010 Jan;9(1):105-18. (PMID: 20083041)
      Health Policy. 2003 Dec;66(3):239-46. (PMID: 14637009)
      Acta Neurol Scand. 2008 Oct;118(4):268-74. (PMID: 18384454)
      Stroke. 2005 Aug;36(8):1776-81. (PMID: 16020772)
      JAMA. 2000 Jun 21;283(23):3102-9. (PMID: 10865305)
      J Stroke Cerebrovasc Dis. 2015 Sep;24(9):1969-77. (PMID: 26166419)
      J Phys Ther Sci. 2015 Mar;27(3):799-803. (PMID: 25931734)
      Circulation. 2017 Feb 21;135(8):759-771. (PMID: 28052979)
      Lancet Neurol. 2019 Apr;18(4):394-405. (PMID: 30878104)
      J Stroke Cerebrovasc Dis. 2015 May;24(5):988-92. (PMID: 25813063)
      Neuroepidemiology. 2018;51(3-4):115-122. (PMID: 30089305)
      Stroke. 1998 Feb;29(2):447-53. (PMID: 9472888)
      Soc Sci Med. 2019 Aug;235:112386. (PMID: 31272079)
      Eur J Cardiovasc Nurs. 2019 Dec;18(8):753-763. (PMID: 31480908)
      BMJ Open. 2018 Mar 30;8(3):e017693. (PMID: 29602836)
      Stroke. 1996 Nov;27(11):1937-43. (PMID: 8898795)
      J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):861-8. (PMID: 23954598)
      Health Policy Plan. 2019 Sep 1;34(7):483-491. (PMID: 31363744)
      J Hypertens. 2009 May;27(5):1056-63. (PMID: 19405168)
      Clin Neurol Neurosurg. 2011 Feb;113(2):111-4. (PMID: 21036465)
      Lancet. 2017 Feb 11;389(10069):641-654. (PMID: 27637676)
      Stroke. 2004 May;35(5):1209-15. (PMID: 15073405)
      Value Health. 2004 Mar-Apr;7(2):144-52. (PMID: 15164804)
    • Grant Information:
      201502017 the National Health and Family Planning Commission (Beijing, China)
    • Contributed Indexing:
      Keywords: China; Hospitalization costs; Multicenter; Prospective observational study; Stroke subtype
    • Publication Date:
      Date Created: 20200930 Date Completed: 20210204 Latest Revision: 20210204
    • Publication Date:
      20231215
    • Accession Number:
      PMC7526192
    • Accession Number:
      10.1186/s12913-020-05758-6
    • Accession Number:
      32993613